{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:43:46Z","timestamp":1794008626136,"version":"4.8.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key R&D Program of Shandong Province, China","award":["No. 2025CXPT036"],"award-info":[{"award-number":["No. 2025CXPT036"]}]},{"name":"Yantai Science and Technology Innovation Development Plan","award":["2024JCYJ060"],"award-info":[{"award-number":["2024JCYJ060"]}]},{"name":"Yantai Science and Technology Innovation Development Plan","award":["2024JCYJ057"],"award-info":[{"award-number":["2024JCYJ057"]}]},{"name":"Taishan Scholars Construction Engineering","award":["tstp20250539"],"award-info":[{"award-number":["tstp20250539"]}]},{"name":"Key R&D Program of Shandong Province","award":["No. 2023CXPT012"],"award-info":[{"award-number":["No. 2023CXPT012"]}]},{"name":"the \"Case-by-Case Introduction of Top Talent (Teams)\" Program in Yantai"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04768-6","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:55:08Z","timestamp":1783086908000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel Au-Se nanoplatform for co-delivery of cGAMP and acriflavine synergizes with photothermal therapy to enhance anti-tumor immunity via STING activation and HIF-1\u03b1 inhibition"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuanyuan","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renhui","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"4768_CR1","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/curroncol29050247","volume":"29","author":"Y Shiravand","year":"2022","unstructured":"Shiravand Y, Khodadadi F, Kashani SMA, Hosseini-Fard SR, Hosseini S, Sadeghirad H, Ladwa R, O\u2019Byrne K, Kulasinghe A. Immune Checkpoint Inhibitors in Cancer Therapy. Curr Oncol. 2022;29:3044\u201360. https:\/\/doi.org\/10.3390\/curroncol29050247.","journal-title":"Curr Oncol"},{"key":"4768_CR2","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/ijd.14945","volume":"59","author":"L Roncati","year":"2020","unstructured":"Roncati L, Palmieri B. Adoptive cell transfer (ACT) of autologous tumor-infiltrating lymphocytes (TILs) to treat malignant melanoma: the dawn of a chimeric antigen receptor T (CAR-T) cell therapy from autologous donor. Int J Dermatol. 2020;59:763\u20139. https:\/\/doi.org\/10.1111\/ijd.14945.","journal-title":"Int J Dermatol"},{"key":"4768_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","volume":"15","author":"D Fukumura","year":"2018","unstructured":"Fukumura D, Kloepper J, Amoozgar Z, Duda DG, Jain RK. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nat Rev Clin Oncol. 2018;15:325\u201340. https:\/\/doi.org\/10.1038\/nrclinonc.2018.29.","journal-title":"Nat Rev Clin Oncol"},{"key":"4768_CR4","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.26355\/eurrev_201806_15270","volume":"22","author":"J-J Wang","year":"2018","unstructured":"Wang J-J, Lei K-F, Han F. Tumor microenvironment: recent advances in various cancer treatments. Eur Rev Med Pharmacol Sci. 2018;22:3855\u201364. https:\/\/doi.org\/10.26355\/eurrev_201806_15270.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4768_CR5","unstructured":"Yuan SY, Rigor RR. Regulation of Endothelial Barrier Function, Morgan & Claypool Life Sciences, San Rafael (CA), 2010. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK54117\/ (accessed January 11, 2026)."},{"key":"4768_CR6","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1161\/STROKEAHA.108.533638","volume":"40","author":"C Iadecola","year":"2009","unstructured":"Iadecola C, Park L, Capone C. Threats to the mind: aging, amyloid, and hypertension. Stroke. 2009;40:S40\u201344. https:\/\/doi.org\/10.1161\/STROKEAHA.108.533638.","journal-title":"Stroke"},{"key":"4768_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12935-023-03003-8","volume":"23","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Yu J, Huang A, Yang Q, Li G, Yang Y, Chen Y. ROS impairs tumor vasculature normalization through an endocytosis effect of caveolae on extracellular SPARC. Cancer Cell Int. 2023;23:152. https:\/\/doi.org\/10.1186\/s12935-023-03003-8.","journal-title":"Cancer Cell Int"},{"key":"4768_CR8","doi-asserted-by":"publisher","first-page":"7351","DOI":"10.7150\/thno.74753","volume":"12","author":"H Zeng","year":"2022","unstructured":"Zeng H, Hou Y, Zhou X, Lang L, Luo H, Sun Y, Wan X, Yuan T, Wang R, Liu Y, Tang R, Cheng S, Xu M, Liu M. Cancer-associated fibroblasts facilitate premetastatic niche formation through lncRNA SNHG5-mediated angiogenesis and vascular permeability in breast cancer. Theranostics. 2022;12:7351\u201370. https:\/\/doi.org\/10.7150\/thno.74753.","journal-title":"Theranostics"},{"key":"4768_CR9","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1111\/cas.15956","volume":"114","author":"K Yang","year":"2023","unstructured":"Yang K, Xu C, Sun H, Xuan Z, Liu Y, Li J, Bai Y, Zheng Z, Zhao Y, Shi Z, Zheng J, Shao C. Branched-chain keto-acid dehydrogenase kinase regulates vascular permeability and angiogenesis to facilitate tumor metastasis in renal cell carcinoma. Cancer Sci. 2023;114:4270\u201385. https:\/\/doi.org\/10.1111\/cas.15956.","journal-title":"Cancer Sci"},{"key":"4768_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/mc.23525","volume":"62","author":"L Xie","year":"2023","unstructured":"Xie L, Zhang K, You B, Yin H, Zhang P, Shan Y, Gu Z, Zhang Q. Hypoxic nasopharyngeal carcinoma-derived exosomal miR-455 increases vascular permeability by targeting ZO-1 to promote metastasis. Mol Carcinog. 2023;62:803\u201319. https:\/\/doi.org\/10.1002\/mc.23525.","journal-title":"Mol Carcinog"},{"key":"4768_CR11","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3390\/biom13040702","volume":"13","author":"AL White","year":"2023","unstructured":"White AL, Bix GJ. VEGFA Isoforms as Pro-Angiogenic Therapeutics for Cerebrovascular Diseases. Biomolecules. 2023;13:702. https:\/\/doi.org\/10.3390\/biom13040702.","journal-title":"Biomolecules"},{"key":"4768_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/joim.12019","volume":"273","author":"L Claesson-Welsh","year":"2013","unstructured":"Claesson-Welsh L, Welsh M. VEGFA and tumour angiogenesis. J Intern Med. 2013;273:114\u201327. https:\/\/doi.org\/10.1111\/joim.12019.","journal-title":"J Intern Med"},{"key":"4768_CR13","doi-asserted-by":"publisher","first-page":"103189","DOI":"10.1016\/j.bioorg.2019.103189","volume":"92","author":"OH Rizk","year":"2019","unstructured":"Rizk OH, Teleb M, Abu-Serie MM, Shaaban OG. Dual VEGFR-2\/PIM-1 kinase inhibition towards surmounting the resistance to antiangiogenic agents via hybrid pyridine and thienopyridine-based scaffolds: Design, synthesis and biological evaluation. Bioorg Chem. 2019;92:103189. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103189.","journal-title":"Bioorg Chem"},{"key":"4768_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12974-025-03563-8","volume":"22","author":"H Li","year":"2025","unstructured":"Li H, Cai R, Zhou Y, Jiang Y, Tan S. cGAS-STING signaling in brain aging and neurodegeneration: molecular links and therapeutic perspectives. J Neuroinflammation. 2025;22:235. https:\/\/doi.org\/10.1186\/s12974-025-03563-8.","journal-title":"J Neuroinflammation"},{"key":"4768_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13024-025-00815-2","volume":"20","author":"S Quan","year":"2025","unstructured":"Quan S, Fu X, Cai H, Ren Z, Xu Y, Jia L. The neuroimmune nexus: unraveling the role of the mtDNA-cGAS-STING signal pathway in Alzheimer\u2019s disease. Mol Neurodegener. 2025;20:25. https:\/\/doi.org\/10.1186\/s13024-025-00815-2.","journal-title":"Mol Neurodegener"},{"key":"4768_CR16","doi-asserted-by":"publisher","first-page":"1150705","DOI":"10.3389\/fimmu.2023.1150705","volume":"14","author":"HTW Blest","year":"2023","unstructured":"Blest HTW, Chauveau L. cGAMP the travelling messenger. Front Immunol. 2023;14:1150705. https:\/\/doi.org\/10.3389\/fimmu.2023.1150705.","journal-title":"Front Immunol"},{"key":"4768_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nm.4027","volume":"22","author":"C Lood","year":"2016","unstructured":"Lood C, Blanco LP, Purmalek MM, Carmona-Rivera C, De Ravin SS, Smith CK, Malech HL, Ledbetter JA, Elkon KB, Kaplan MJ. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med. 2016;22:146\u201353. https:\/\/doi.org\/10.1038\/nm.4027.","journal-title":"Nat Med"},{"key":"4768_CR18","doi-asserted-by":"publisher","first-page":"EBC20253006","DOI":"10.1042\/EBC20253006","volume":"69","author":"B Yue","year":"2025","unstructured":"Yue B, Gao W, Lovell JF, Jin H, Huang J. The cGAS-STING pathway in cancer immunity: dual roles, therapeutic strategies, and clinical challenges. Essays Biochem. 2025;69:EBC20253006. https:\/\/doi.org\/10.1042\/EBC20253006.","journal-title":"Essays Biochem"},{"key":"4768_CR19","doi-asserted-by":"publisher","first-page":"e001906","DOI":"10.1136\/jitc-2020-001906","volume":"9","author":"M Chelvanambi","year":"2021","unstructured":"Chelvanambi M, Fecek RJ, Taylor JL, Storkus WJ. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment. J Immunother Cancer. 2021;9:e001906. https:\/\/doi.org\/10.1136\/jitc-2020-001906.","journal-title":"J Immunother Cancer"},{"key":"4768_CR20","doi-asserted-by":"publisher","first-page":"eadd1153","DOI":"10.1126\/sciimmunol.add1153","volume":"8","author":"L Wang-Bishop","year":"2023","unstructured":"Wang-Bishop L, Kimmel BR, Ngwa VM, Madden MZ, Baljon JJ, Florian DC, Hanna A, Pastora LE, Sheehy TL, Kwiatkowski AJ, Wehbe M, Wen X, Becker KW, Garland KM, Schulman JA, Shae D, Edwards D, Wolf MM, Delapp R, Christov PP, Beckermann KE, Balko JM, Rathmell WK, Rathmell JC, Chen J, Wilson JT. STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy. Sci Immunol. 2023;8:eadd1153. https:\/\/doi.org\/10.1126\/sciimmunol.add1153.","journal-title":"Sci Immunol"},{"key":"4768_CR21","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1002\/jcp.25726","volume":"232","author":"C Li","year":"2017","unstructured":"Li C, Liu T, Bazhin AV, Yang Y. The Sabotaging Role of Myeloid Cells in Anti-Angiogenic Therapy: Coordination of Angiogenesis and Immune Suppression by Hypoxia. J Cell Physiol. 2017;232:2312\u201322. https:\/\/doi.org\/10.1002\/jcp.25726.","journal-title":"J Cell Physiol"},{"key":"4768_CR22","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.3390\/ijms25042060","volume":"25","author":"S Musleh Ud Din","year":"2024","unstructured":"Musleh Ud Din S, Streit SG, Huynh BT, Hana C, Abraham A-N, Hussein A. Therapeutic Targeting of Hypoxia-Inducible Factors in Cancer. Int J Mol Sci. 2024;25:2060. https:\/\/doi.org\/10.3390\/ijms25042060.","journal-title":"Int J Mol Sci"},{"key":"4768_CR23","doi-asserted-by":"publisher","first-page":"790661","DOI":"10.3389\/fimmu.2021.790661","volume":"12","author":"H Zhuang","year":"2021","unstructured":"Zhuang H, Wang S, Chen B, Zhang Z, Ma Z, Li Z, Liu C, Zhou Z, Gong Y, Huang S, Hou B, Chen Y, Zhang C. Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas. Front Immunol. 2021;12:790661. https:\/\/doi.org\/10.3389\/fimmu.2021.790661.","journal-title":"Front Immunol"},{"key":"4768_CR24","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1124\/mol.106.027029","volume":"70","author":"Q Ke","year":"2006","unstructured":"Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol. 2006;70:1469\u201380. https:\/\/doi.org\/10.1124\/mol.106.027029.","journal-title":"Mol Pharmacol"},{"key":"4768_CR25","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jjcc.2022.09.002","volume":"81","author":"T Sato","year":"2023","unstructured":"Sato T, Takeda N. The roles of HIF-1\u03b1 signaling in cardiovascular diseases. J Cardiol. 2023;81:202\u20138. https:\/\/doi.org\/10.1016\/j.jjcc.2022.09.002.","journal-title":"J Cardiol"},{"key":"4768_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fnmol.2011.00051","volume":"4","author":"J Karar","year":"2011","unstructured":"Karar J, Maity A. PI3K\/AKT\/mTOR Pathway in Angiogenesis. Front Mol Neurosci. 2011;4:51. https:\/\/doi.org\/10.3389\/fnmol.2011.00051.","journal-title":"Front Mol Neurosci"},{"key":"4768_CR27","doi-asserted-by":"publisher","first-page":"11415","DOI":"10.1021\/acs.jmedchem.2c00573","volume":"65","author":"K Piorecka","year":"2022","unstructured":"Piorecka K, Kurjata J, Stanczyk WA. Acriflavine, an Acridine Derivative for Biomedical Application: Current State of the Art. J Med Chem. 2022;65:11415\u201332. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00573.","journal-title":"J Med Chem"},{"key":"4768_CR28","doi-asserted-by":"publisher","first-page":"1271118","DOI":"10.3389\/fimmu.2023.1271118","volume":"14","author":"JJ Anders","year":"2023","unstructured":"Anders JJ, Elwood BW, Kardon RH, Gramlich OW. Acriflavine, a HIF-1 inhibitor, preserves vision in an experimental autoimmune encephalomyelitis model of optic neuritis. Front Immunol. 2023;14:1271118. https:\/\/doi.org\/10.3389\/fimmu.2023.1271118.","journal-title":"Front Immunol"},{"key":"4768_CR29","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1002\/anie.201712921","volume":"57","author":"B Hu","year":"2018","unstructured":"Hu B, Kong F, Gao X, Jiang L, Li X, Gao W, Xu K, Tang B. Avoiding Thiol Compound Interference: A Nanoplatform Based on High-Fidelity Au-Se Bonds for Biological Applications. Angew Chem Int Ed Engl. 2018;57:5306\u20139. https:\/\/doi.org\/10.1002\/anie.201712921.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4768_CR30","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.actbio.2024.12.027","volume":"193","author":"M Song","year":"2025","unstructured":"Song M, Yuan J, Zhang G, Sun M, Zhang Y, Su X, Lv R, Zhao Y, Shi Y, Zhao L. Mitochondrial transfer of drug-loaded artificial mitochondria for enhanced anti-Glioma therapy through synergistic apoptosis\/ferroptosis\/immunogenic cell death. Acta Biomater. 2025;193:514\u201330. https:\/\/doi.org\/10.1016\/j.actbio.2024.12.027.","journal-title":"Acta Biomater"},{"key":"4768_CR31","doi-asserted-by":"publisher","first-page":"37600","DOI":"10.1021\/acsnano.5c08243","volume":"19","author":"G Jiang","year":"2025","unstructured":"Jiang G, Zhang F, Wu Z, Zhang X, Xu J, Peng Z, Li G, Zhu G, Wang X, Xie W. Targeting Mitochondrial Oxidative Stress by Calcium\/Copper\/Elesclomol Tri-Overloaded Nanocages for Osteosarcoma Immunotherapy via Immunogenic Cell Death. ACS Nano. 2025;19:37600\u201316. https:\/\/doi.org\/10.1021\/acsnano.5c08243.","journal-title":"ACS Nano"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04768-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04768-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04768-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:06:53Z","timestamp":1790255213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04768-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4768"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04768-6","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"897"}}